Peng, J., Zhang, X., Song, J., Ran, L., Luo, R., Li, H., & Wang, Y. (2019). Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma. Medicine (Baltimore).
Citação norma ChicagoPeng, Jian-Heng, Xiang Zhang, Jun-Long Song, Liang Ran, Rong Luo, Hong-Yuan Li, and Yong-Hong Wang. "Neoadjuvant Chemotherapy Reduces the Expression Rates of ER, PR, HER2, Ki67, and P53 of Invasive Ductal Carcinoma." Medicine (Baltimore) 2019.
MLA citiranjePeng, Jian-Heng, et al. "Neoadjuvant Chemotherapy Reduces the Expression Rates of ER, PR, HER2, Ki67, and P53 of Invasive Ductal Carcinoma." Medicine (Baltimore) 2019.
Opozorilo: Ti citati niso vedno 100% točni.